Next, we measured the frequency of CDKN2A LoF in 257 BEs that progressed to high-grade dysplasia or EAC (P-BEs), again sequenced for this study or gathered from published datasets15,40,42–44 (Supplementary Table 1 and Extended Data Fig. 1f–j). This evidence concerns the gene CDKN2A and dysplasia.